Vatave Pharmacls India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 143.80%
(FY 2022)
- Profit 153.11%
(FY 2022)
- Ebitda 73.18%
(FY 2022)
- Net Worth 375.74%
(FY 2022)
- Total Assets 155.28%
(FY 2022)
About Vatave Pharmacls India
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Uday Singh and Upendra serve as directors at the Company.
- CIN/LLPIN
U51397CH2019PTC042644
- Company No.
042644
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Vatave Pharmacls India Private Limited offer?
Vatave Pharmacls India Private Limited offers a wide range of products and services, including Common Disease Medicines, Skin Lightening Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Multivitamin Syrup & Drops, Mineral Supplement, Pharmaceutical Medicine, Pharmaceutical Capsules.
Who are the key members and board of directors at Vatave Pharmacls India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uday Singh  | Director | 02-Feb-2023 | Current |
| Upendra | Director | 26-Jul-2019 | Current |
Financial Performance of Vatave Pharmacls India.
Vatave Pharmacls India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 143.8% increase. The company also saw a substantial improvement in profitability, with a 153.11% increase in profit. The company's net worth Soared by an impressive increase of 375.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vatave Pharmacls India?
Unlock access to Vatave Pharmacls India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vatave Pharmacls India?
Unlock and access historical data on people associated with Vatave Pharmacls India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vatave Pharmacls India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vatave Pharmacls India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
